A surprising recent finding was that PD-1 blockade, besides inducing recovery of dysfunctional PD-1+ T cells, enhances the immunosuppressive function of PD-1+ Treg thereby promoting cancer hyperprogression [62,63]. Here, PDCD1 is linked to cancer.